|
SMARCB1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.578010E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.394310E-04 |
| Normal-vs-Stage2 |
3.178600E-01 |
| Normal-vs-Stage3 |
9.915800E-03 |
| Normal-vs-Stage4 |
1.503810E-01 |
| Stage1-vs-Stage2 |
2.759200E-01 |
| Stage1-vs-Stage3 |
6.963400E-01 |
| Stage1-vs-Stage4 |
4.186800E-01 |
| Stage2-vs-Stage3 |
4.639800E-01 |
| Stage2-vs-Stage4 |
8.096200E-01 |
| Stage3-vs-Stage4 |
6.360000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.91750000000379E-06 |
| Normal-vs-AfricanAmerican |
9.644400E-01 |
| Normal-vs-Asian |
4.932000E-02 |
| Caucasian-vs-AfricanAmerican |
4.662000E-02 |
| Caucasian-vs-Asian |
4.952600E-01 |
| AfricanAmerican-vs-Asian |
2.179200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.421760E-02 |
| Normal-vs-Female |
2.009600E-04 |
| Male-vs-Female |
7.139200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.440560E-03 |
| Normal-vs-Age(41-60Yrs) |
2.175600E-03 |
| Normal-vs-Age(61-80Yrs) |
1.980800E-01 |
| Normal-vs-Age(81-100Yrs) |
5.50790000000134E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.276800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.738750E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.259800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.316600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.317900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.120500E-03 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.228600E-01 |
| Classical-VS-Follicular |
4.77970000001271E-06 |
| Classical-VS-Other |
4.005000E-01 |
| Classical-VS-Normal |
9.40869999688232E-08 |
| Tall-VS-Follicular |
7.221800E-04 |
| Tall-VS-Other |
3.783200E-01 |
| Tall-VS-Normal |
4.175100E-03 |
| Follicular-VS-Other |
6.677000E-01 |
| Follicular-VS-Normal |
1.551640E-01 |
| Other-VS-Normal |
9.882400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.642400E-03 |
| Normal-vs-N1 |
4.183200E-01 |
| N0-vs-N1 |
4.329600E-01 |
|
|
